Daffodils as potential crops of galanthamine. Assessment of more than 100 ornamental varieties for their alkaloid content and acetylcholinesterase inhibitory activity

Industrial Crops and Products

Volumn 43, Issue 1, 2013, Pages 237-244

  Torras Claveria, Laura ^a   Berkov, Strahil ^b   Codina, Carles ^a   Viladomat, Francesc ^a   Bastida, Jaume ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b AGROBIOINSTITUTE   (Bulgaria)

Author keywords

Acetylcholinesterase; Amaryllidaceae alkaloids; Daffodils; Galanthamine; GC MS; Narcissus cultivars; Sanguinine

Indexed keywords

ACETYLCHOLINESTERASE; AMARYLLIDACEAE; DAFFODILS; GALANTHAMINE; GC-MS; NARCISSUS CULTIVARS; SANGUININE;

BIOACTIVITY; CULTIVATION; METABOLITES; NITROGEN COMPOUNDS;

PLANTS (BOTANY);

ALKALOID; BIOACTIVITY; CONCENTRATION (COMPOSITION); CULTIVAR; DISEASE TREATMENT; ENZYME ACTIVITY; INHIBITOR; LEAF; MONOCOTYLEDON; ORGANIC COMPOUND; ORNAMENTAL SPECIES; PHYTOCHEMISTRY;

AMARYLLIDACEAE; NARCISSUS; NARCISSUS HISPANICUS;

EID: 84864542799     PISSN: 09266690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.indcrop.2012.07.034     Document Type: Article

References (23)

1. Bastida J., Lavilla R., Viladomat F. Chemical and biological aspects of Narcissus alkaloids. The Alkaloids 2006, 87-179. Elsevier, Chicago. G.A. Cordell (Ed.).
2. Bastida J., Berkov S., Torras L., Pigni N.B., de Andrade J.P., Martínez V., Codina C., Viladomat F. Chemical and biological aspects of Amaryllidaceae alkaloids. Recent Advances in Pharmaceutical Sciences 2011, 65-100. Transworld Research Network, Kerala. D. Muñoz-Torrero (Ed.).
3. Berkov S., Bastida J., Viladomat F., Codina C. Development and validation of a GC-MS method for rapid determination of galanthamine in Leucojum aestivum and Narcissus ssp.: a metabolomic approach. Talanta 2011, 83:1455-1465.
4. Berkov S., Georgieva V., Kondakova V., Atanassov A., Viladomat F., Bastida J., Codina C. Plant sources of galanthamine: phytochemical and biotechnological aspects. Biotechnol. Biotechnol. Equip. 2009, 23:1170-1176.
5. Bores G.M., Huger F.P., Petko W., Mutlib A.E., Camacho F., Rush D.K., Selk D.E., Wolf V., Kosley R.W., Davis L., Vargas H.M. Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine. J. Pharmacol. Exp. Ther. 1996, 277:728-738.
6. Cherkasov O.A., Tolkachev O.N. Narcissus and other Amaryllidaceae as sources of galanthamine. Narcissus and Daffodil. The Genus Narcissus 2002, 243-255. Taylor & Francis, London. G.R. Hanks (Ed.).
7. Ellman G.L., Courtney K.D., Andres V., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-90.
8. Gorinova N.I., Atanassov A., Stojanov D., Tencheva J. Influence of chemical composition of soil on the galanthamine content in Leucojum aestivum. J. Plant Nutr. 1993, 16:1631-1636.
9. Heinrich M., Teoh H.L. Galanthamine from snowdrop-the development of a modern drug against Alzheimer's disease from local Caucassian knowledge. J. Ethnopharmacol. 2004, 92:147-162.
10. Ingkaninan K., Hazecamp A., de Best C.M., Irth H., Tjaden U.R., van der Heijden R., van der Greef J., Verpoorte R. The application of HPLC with on-line coupled UV/MS-biochemical detection for isolation of an acetylcholinesterase inhibitor from Narcissus 'Sir Winston Churchill'. J. Nat. Prod. 2000, 63:803-806.
11. Kington S. The International Daffodil Register and Classified List 2008 2008, Royal Horticultural Society, London.
12. Kreh M. Studies on galanthamine extraction from Narcissus and other Amaryllidaceae. Narcissus and Daffodil. The genus Narcissus 2002, 256-272. Taylor & Francis, London. G.R. Hanks (Ed.).
13. López S., Bastida J., Viladomat F., Codina C. Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts. Life Sci. 2002, 71:2521-2529.
14. López S., Bastida J., Viladomat F., Codina C. Galanthamine pattern in Narcissus confusus plants. Planta Med. 2003, 69:1166-1168.
15. 1H NMR. Phytochem. Anal. 2010, 21:66-72.
16. 1H NMR. J. Agric. Food Chem. 2011, 59:3155-3161.
17. Maelicke A., Samochocki M., Jostock R., Fehrenbacher A., Ludwig J., Albuquerque E.X., Zerlin M. Allosteric sensitization of nicotinic receptors by galanthamine, a new treatment strategy for Alzheimer's disease. Biol. Psychiatry 2001, 49:2479-3288.
18. Martindale, 2011. The Complete Drug Reference. Pharmaceutical Press, London, United Kingdom. (online, accessed February 2012). http://www.medicinescomplete.com/.
19. Moraes R.M. Galanthamine production from Narcissus: agronomic and related considerations. Narcissus and Daffodil. The genus Narcissus. 2002, 273-285. Taylor & Francis, London. G.R. Hanks (Ed.).
20. Moraes-Cerdeira R.M., Burandt C.L., Bastos J.K., Nanayakkara N.P.D., Mikell J., Thurn J., McChesney J.D. Evaluation of four Narcissus cultivars as potential sources for galanthamine production. Planta Med. 1997, 63:472-474.
21. Rønsted N., Savolainen V., Mølgaard P., Jäger A.K. Phylogenetic selection of Narcissus species for drug discovery. Biochem. Syst. Ecol. 2008, 36:417-422.
22. Torras-Claveria L., Berkov S., Jáuregui O., Caujapé J., Viladomat F., Codina C., Bastida J. Metabolic profiling of bioactive Pancratium canariense extracts by GC-MS. Phytochem. Anal. 2010, 21:80-88.
23. Zhejiang Yixin Pharmaceutical Co., Ltd., 2012. Lanxi, China. (accessed February 2012). http://www.galantamine.cn/galantamine.php.